Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Hebei Aoxing Pharmaceutical Group, a subsidiary of Aoxing Pharmaceutical Company, has received a patent by the State Intellectual Property Office of The People's Republic of China for naloxone sublingual film.
Subscribe to our email newsletter
Naloxone is an opioid receptor antagonist used clinically to relieve life threatening depression of the central nervous system and respiratory system caused by overdose of morphine and other opioids.
It may also be used as an adjunctive therapy to increase blood pressure in the treatment of septic shocks.
The Chinese patent, ‘ZL2005.1.0125279.7,’ covers a unique sublingual film formulation of naloxone that can be dissolved rapidly under the tongue in 30 seconds and allows the drug to diffuse into the blood.